RGLS : Summary for Regulus Therapeutics Inc. - Yahoo Finance

U.S. Markets closed

Regulus Therapeutics Inc. (RGLS)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.50-0.10 (-3.85%)
At close: 4:00 PM EST
People also watch:
PTCTPTLACEMPEPZMOMED
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.60
Open2.65
Bid2.40 x 1000
Ask2.60 x 100
Day's Range2.35 - 2.65
52 Week Range2.13 - 10.18
Volume676,875
Avg. Volume435,417
Market Cap132.31M
Beta2.40
PE Ratio (TTM)-1.91
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investopediayesterday

    Regulus Expands Liver and Kidney Drug Pipeline

    Regulus added two new clinical drug candidates to treat liver and kidney diseases.

  • PR Newswire3 days ago

    Regulus Announces New Drug Development Candidates

    LA JOLLA, Calif., Dec. 6, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced two new drug development candidates at its R&D day, held in New York. "We are delighted to announce the addition of two new drug candidates to our growing portfolio of potential microRNA therapeutics.

  • PR Newswire17 days ago

    Regulus to Announce New Drug Development Candidates at R&D Day on December 6, 2016

    LA JOLLA, Calif., Nov. 22, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will host a R&D day on Tuesday, December 6, 2016 from 8:30 a.m. to 11:30 a.m. EST in New York City where it plans to announce new development candidates. Interested parties may access a live audio webcast and slides of the presentations on the investor section of Regulus' website at www.regulusrx.com beginning at 8:30 a.m. EST.